Telo Genomics Corp $ 0.19 0 (0%)
Warning! GuruFocus has detected 2 Severe warning signs with TDSGF. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Telo Genomics Corp () from 2016 to Sep 19 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Telo Genomics stock (TDSGF) PE ratio as of Sep 19 2020 is 0. More Details
Telo Genomics PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Telo Genomics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare XCNQ:CGN XCNQ:IZO TSXV:AVCR TSXV:MBI.H TSX:SZLS XCNQ:RELA NYSE:TMO NYSE:DHR NAS:ILMN XAMS:PHIA XSWX:LONN NAS:DXCM NYSE:IQV NYSE:A NAS:IDXX SHSE:603259 NYSE:MTD XPAR:BIM NYSE:LH TSE:6869
Address 101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Telo Genomics Corp is a personalized medicine company. The company through its wholly owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. Its proprietary software platform based on the three-dimensional analysis of chromosomal signatures. The company is developing diagnostic and prognostic products for cancers and neurological disorders.